Xianlong Chen, Shengwei Mo, Yue Zhang, Heng Ma, Zhaohui Lu, Shuangni Yu, & Jie Chen. (2022). Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma. Wiley.
Chicago Style (17th ed.) CitationXianlong Chen, Shengwei Mo, Yue Zhang, Heng Ma, Zhaohui Lu, Shuangni Yu, and Jie Chen. Analysis of a Novel Immune Checkpoint, Siglec‐15, in Pancreatic Ductal Adenocarcinoma. Wiley, 2022.
MLA (9th ed.) CitationXianlong Chen, et al. Analysis of a Novel Immune Checkpoint, Siglec‐15, in Pancreatic Ductal Adenocarcinoma. Wiley, 2022.
Warning: These citations may not always be 100% accurate.